Compass Therapeutics Inc
(CMPX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,310 | 2,800 | 1,940 | 1,120 | 2,200 |
| Depreciation Amortization | 2,560 | 1,700 | 1,280 | 670 | 1,980 |
| Other Working Capital | -650 | -2,240 | -940 | -770 | 3,560 |
| Other Operating Activity | -1,060 | 190 | 0 | -10 | -2,400 |
| Operating Cash Flow | $4,160 | $2,450 | $2,280 | $1,010 | $5,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -710 | -260 | -230 | -320 | -1,230 |
| Net Acquisitions | -200 | 0 | 0 | 0 | -13,030 |
| Other Investing Activity | -80 | -480 | -630 | 50 | 1,690 |
| Investing Cash Flow | $-990 | $-740 | $-860 | $-270 | $-12,570 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -4,020 | -2,000 | -2,170 | -1,220 | 8,980 |
| Financing Cash Flow | $-4,020 | $-2,000 | $-2,170 | $-1,220 | $8,980 |
| Exchange Rate Effect | -600 | -310 | 30 | -180 | -90 |
| Beginning Cash Position | 2,220 | 2,220 | 2,220 | 2,220 | 560 |
| End Cash Position | 750 | 1,620 | 1,510 | 1,560 | 2,220 |
| Net Cash Flow | $-1,460 | $-600 | $-710 | $-660 | $1,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,160 | 2,450 | 2,280 | 1,010 | 5,340 |
| Free Cash Flow | 4,160 | 2,450 | 2,280 | 1,010 | 5,340 |